![](/img/cover-not-exists.png)
Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib
de Almeida Carvalho, Lelia Maria, de Oliveira Sapori Avelar, Sandra, Haslam, Alyson, Gill, Jennifer, Prasad, VinayVolume:
2
Language:
english
Journal:
JAMA Network Open
DOI:
10.1001/jamanetworkopen.2019.16091
Date:
November, 2019
File:
PDF, 760 KB
english, 2019